Sintx Technologies (SINT) Cash from Operations Growth (3y) (2016 - 2026)
Sintx Technologies (SINT) Cash from Operations Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.14 Bn | 173.84 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.35 Bn | 125.47 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 107.95 Bn | 98.73 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.16 Bn | 66.71 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 47.67 Bn | 44.00 Bn | 1.29 Bn | -48.14% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -14.75% |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 50.11% |
| 8 | Smith & Nephew | 26.83 Bn | 26.25 Bn | - | - |
| 9 | Koninklijke Philips | 25.36 Bn | 22.23 Bn | 2.07 Bn | 0.50% |
| 10 | Sintx Technologies | 5.80 Mn | 3.91 Mn | 144,000.00 | 20.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.19% |
| Dec 31, 2025 | -3.73% |
| Sep 30, 2025 | -0.52% |
| Jun 30, 2025 | 1.78% |
| Mar 31, 2025 | 25.76% |
| Dec 31, 2024 | 22.63% |
| Sep 30, 2024 | -2.31% |
| Jun 30, 2024 | 1.36% |
| Mar 31, 2024 | 2.97% |
| Dec 31, 2023 | -14.67% |
| Sep 30, 2023 | -10.39% |
| Jun 30, 2023 | -28.67% |
| Mar 31, 2023 | -12.98% |
| Dec 31, 2022 | -10.51% |
| Sep 30, 2022 | -17.03% |
| Jun 30, 2022 | -15.87% |
| Mar 31, 2022 | -23.24% |
| Dec 31, 2021 | -14.85% |
| Sep 30, 2021 | -9.82% |
| Jun 30, 2021 | 14.07% |